RAINBOW PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: F85039 | LONDON, N9 0TW
Showing results 451-500 of 528
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 15 | 150 | £45 | -48.2% ▼ | |
| 15 | 440 | £286 | -65.2% ▼ | |
| Lercanidipine hydrochloride | 14 | 784 | £70 | -97.7% ▼ |
| Daridorexant | 14 | 402 | £536 | +7.1% ▲ |
| Citalopram hydrochloride | 14 | 420 | £294 | -12.8% ▼ |
| Empagliflozin/metformin | 14 | 788 | £489 | -73.1% ▼ |
| Duloxetine hydrochloride | 14 | 700 | £158 | -72.7% ▼ |
| Leuprorelin acetate | 14 | 14 | £3.0K | -69.8% ▼ |
| Sodium feredetate | 14 | 7,000 | £199 | -51.1% ▼ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 14 | 784 | £410 | -45.5% ▼ |
| Ipratropium bromide | 14 | 14 | £102 | -13.7% ▼ |
| Clindamycin/tretinoin | 14 | 510 | £193 | +19.3% ▲ |
| 14 | 98 | £123 | -33.8% ▼ | |
| 14 | 40 | £470 | -49.7% ▼ | |
| Labetalol hydrochloride | 13 | 728 | £111 | -42.7% ▼ |
| Lofepramine hydrochloride | 13 | 1,092 | £469 | -56.5% ▼ |
| Linagliptin | 13 | 448 | £506 | -96.8% ▼ |
| Cabergoline | 13 | 104 | £176 | -16.2% ▼ |
| Epoetin beta | 13 | 78 | £10.9K | +269.6% ▲ |
| Azelastine hydrochloride | 13 | 104 | £79 | +9.4% ▲ |
| Chlorhexidine gluconate | 13 | 4,100 | £32 | -40.8% ▼ |
| 13 | 250 | £45 | -61.0% ▼ | |
| 13 | 390 | £215 | +25.9% ▲ | |
| 13 | 480 | £1.3K | +10.4% ▲ | |
| 13 | 556 | £70 | -83.8% ▼ | |
| 13 | 390 | £961 | -14.7% ▼ | |
| Sennosides | 12 | 5,950 | £112 | -61.1% ▼ |
| Olmesartan medoxomil | 12 | 392 | £13 | -82.6% ▼ |
| INR blood testing reagents | 12 | 528 | £1.5K | +59.3% ▲ |
| Dabigatran etexilate | 12 | 720 | £591 | -76.8% ▼ |
| Salmeterol | 12 | 12 | £334 | -50.1% ▼ |
| Simple | 12 | 2,600 | £21 | +4.5% ▲ |
| Doxepin | 12 | 336 | £868 | -7.7% ▼ |
| Perampanel | 12 | 336 | £1.6K | -44.6% ▼ |
| RtS 1.5 - 1.6 kcal/ml milkshake with fibre (0913011) | 12 | 201.6K | £3.0K | -9.7% ▼ |
| Powder extensively hydrolysed formula (0913101) | 12 | 19.6K | £624 | -83.3% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 12 | 30.7K | £473 | -47.6% ▼ |
| Tube feed 1.3 kcal/ml peptide based (0914032) | 12 | 314.0K | £6.7K | +37.1% ▲ |
| Diclofenac potassium | 12 | 542 | £68 | +231.7% ▲ |
| Chlorhexidine gluconate | 12 | 3,500 | £79 | -59.4% ▼ |
| 12 | 81 | £83 | +15.5% ▲ | |
| 12 | 600 | £40 | -82.8% ▼ | |
| 12 | 120 | £133 | -84.5% ▼ | |
| 12 | 910 | £166 | -62.2% ▼ | |
| 12 | 310 | £1.4K | -53.6% ▼ | |
| Telmisartan with diuretic | 11 | 308 | £84 | -2.7% ▼ |
| Salbutamol | 11 | 460 | £175 | +63.8% ▲ |
| Cinnarizine | 11 | 852 | £39 | -76.5% ▼ |
| Ondansetron hydrochloride | 11 | 438 | £226 | -77.3% ▼ |
| Amantadine hydrochloride | 11 | 616 | £161 | -60.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.